Alprazolam and diazepam: Addiction potential
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Alprazolam and diazepam, the two most prescribed benzodiazepine anxiolytics in the United States, have potential for addictive use. The Drug Abuse Warning Network (DAWN) indicates they are the most mentioned benzodiazepines, and the National Household Survey indicates significant abuse of tranquilizers. Both drugs are rapidly absorbed and enter the brain tissue rapidly, leading to reinforcement. Alprazolam has a shorter half-life, which may lead to more withdrawal symptoms than diazepam. In experimental conditions, they are among the most reinforcing benzodiazepines. Each causes a withdrawal syndrome, but alprazolam withdrawal may be more severe and may occur after a shorter period of use. Adverse effects from their use are said to be rare, yet subtle negative consequences may be seen with some regularity. Alprazolam deserves special caution because of its relative newness, great popularity, reinforcing capabilities, relatively severe withdrawal syndrome, and reports of addiction and negative consequences of use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is no clear evidence suggesting the increased potency of the triazole moiety is increasing its potential for dependence or addiction, though it is hypothesized that the triazole moiety may have unique receptor-binding effects which are not fully known (Juergens, 1991).”
From A Review of Alprazolam Use, Misuse, and Withdrawal (2018) · cites this paper as Juergens, 1991
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,526
Psychopharmacology: The third generation of progress
O'Connell, R. A. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90057-0 · Cited by 3,013
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,014
DISEASES OF THE NERVOUS SYSTEM
JELLIFFE, S. E., & WHITE, W. A. (1918) · The American Journal of the Medical Sciences · doi:10.1097/00000441-191803000-00015 · Cited by 1,277
(1969) · Occupational Therapy: the Official Journal of the Association of Occupational Therapists · doi:10.1177/030802266903200417 · Cited by 982
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610023151403 · Cited by 369
Abuse liability of benzodiazepines.
Woods, J. H., Katz, J. L., & Winger, G. (1987) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06658-x · Cited by 315 · cited 1×
“Human studies using normal and mildly anxious subjects, have predominantly shown diazepam as not being preferred over placebo (Woods et al., 1987).”
BackgroundBenzodiazepine withdrawal symptoms and propranolol
TYRER, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92861-0 · Cited by 297 · cited 1×
“Others have reported more withdrawal (Busto, Sellars, Naranjo, Cappell, Sanchez-Craig, & Sykora, 1986; Tyrer, Rutherford, & Huggett, 1981) or rebound symptoms (Fontaine, Chouinard, & Annable, 1984), and more subjects who dropped out (Busto, Sellars, Naranjo, Cappell, Sanchez-Craig, & Sykora, 1986; Tyrer et al., 1981)…”
Pecknold, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290043006 · Cited by 204
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.7.848 · Cited by 176
Research works printed but not linked: 5
- Guarino, J.L. & Griffiths, R.R. (1989). Alprazolam: Subjective ef- fects, behavioral effects, and abuse liability in drug abusers. The Pharmacologist, 30, 135.
- Ladewig, D., Banzinger, W., & Lowenheck, M. (1981). Tranquil- izer abuse-Results of a nationwide Swiss survey. Journal of Drug Research, (TNO), 6, 1132-l 137.
- Patterson, 1988, Alprazolam dependency: Use of clonazepam for withdrawal, Southern Medical Journal, 81, 836, 10.1097/00007611-198807000-00006 · DOI · Paper page
- Simonsen, L.L.P. (1989, April). Top 200 drugs of 1988: Branded new Rxs rise 4.0% and total Rxs move up 1.2%. Pharmacy Times, 40-48.
- In L.S. Harris (Ed.), Prob- /ems of drug dependence (pp. 375-376). NIDA Research Mono- graph No. 95, DHHS Publication No. (ADM) 90-1663.
Cited by
Tinnitus Retraining Therapy: Implementing the Neurophysiological Model
Jastreboff, P. J., & Hazell, J. W. P. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544989 · Cited by 248
A Review of Alprazolam Use, Misuse, and Withdrawal
Ait-Daoud, N., Hamby, A. S., Sharma, S., & Blevins, D. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000350 · Cited by 195
“There is no clear evidence suggesting the increased potency of the triazole moiety is increasing its potential for dependence or addiction, though it is hypothesized that the triazole moiety may have unique receptor-binding effects which are not fully known (Juergens, 1991).”
Pharmacological Treatment of Vertigo
Hain, T. C., & Uddin, M. (2003) · CNS Drugs · doi:10.2165/00023210-200317020-00002 · Cited by 159
Tinnitus retraining therapy: A different view on tinnitus
Jastreboff, P. J., & Jastreboff, M. M. (2006) · ORL · doi:10.1159/000090487 · Cited by 154
Benzodiazepine and sedative use/abuse by methadone maintenance clients
Iguchi, M. Y., Handelsman, L., Bickel, W. K., & Griffiths, R. R. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90090-d · Cited by 152
“research settings (Stitzer et al., 1981; Wedding-ton and Carney, 1987; Griffiths and Sannerud, 1987; Ciraulo et al., 1988; Griffiths and Wolf, 1990; Apelt et al., 1990; Juergens, 1991).”
Background
Metadata
- Authors
- Juergens, S.
- Affiliations
- Virginia Mason Medical Center (US)
- Corresponding author
- Juergens, Steven
- Venue
- Journal of Substance Abuse Treatment
- Publisher
- Elsevier BV
- Published
- 1991-01
- Volume
- 8
- Issue
- 1-2
- Pages
- 43-51
- ISSN
- 0740-5472 (ISSN-L)
- OpenAlex
- W2102188940
- Cited by
- 46
- References
- 72
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 3 · 2018: 2 · 2017: 2 · 2016: 1 · 2014: 2 · 2013: 1 · 2012: 1
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Substance Abuse Treatment (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- alprazolam, diazepam, benzodiazepines, drug addiction, benzodiazepine misuse, withdrawal syndrome, drug reinforcement, adverse effects, anxiolytics
- MeSH terms
- Alprazolam, Diazepam, Humans, Risk Factors, Substance Withdrawal Syndrome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alprazolam and diazepam: Addiction potential. https://app.cochat.ai/papers/10.1016/0740-5472(91)90026-7
- The paper
- Juergens, S. (1991). Alprazolam and diazepam: Addiction potential. Journal of Substance Abuse Treatment. https://doi.org/10.1016/0740-5472(91)90026-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.